The Latest Breaking News from WST

West Pharmaceutical Services has substantially underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects, with price targets suggesting significant upside potential.

West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’s third-quarter 2025 earnings surpassed analyst estimates.

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its second-quarter 2025 earnings and revenue, while also significantly raising its full-year guidance.

West Pharmaceutical Services is expected to announce its second-quarter results later this month, with analysts projecting a marginal drop in its bottom line.

While West Pharmaceutical Services has underperformed the broader Nasdaq Composite over the past year, analysts remain confident in its long-term growth prospects, citing strong fundamentals and innovation-driven momentum.

West Pharmaceutical stock has notably lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.

Some fans paid £115 for their seats: ‘It’s pretty much daylight robbery’

Ronnie O’Sullivan’s hopes of an eighth World Snooker Championship crown were destroyed as Zhao Xintong thrashed him 17-7 with a session to spare…

Trump surpassed Neil Robertson’s 11-year-old record with his 104th hundred break of the season.